67 related articles for article (PubMed ID: 19766676)
1. Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).
Amal H; Fridman-Rozevich L; Senn R; Strelnikov A; Gafni M; Keren O; Sarne Y
Behav Brain Res; 2010 Jan; 206(2):245-53. PubMed ID: 19766676
[TBL] [Abstract][Full Text] [Related]
2. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats.
Cha YM; Jones KH; Kuhn CM; Wilson WA; Swartzwelder HS
Behav Pharmacol; 2007 Sep; 18(5-6):563-9. PubMed ID: 17762524
[TBL] [Abstract][Full Text] [Related]
4. A single low dose of tetrahydrocannabinol induces long-term cognitive deficits.
Tselnicker I; Keren O; Hefetz A; Pick CG; Sarne Y
Neurosci Lett; 2007 Jan; 411(2):108-11. PubMed ID: 17092651
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
8. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
Senn R; Keren O; Hefetz A; Sarne Y
Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
[TBL] [Abstract][Full Text] [Related]
9. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus.
Kochman LJ; dos Santos AA; Fornal CA; Jacobs BL
Brain Res; 2006 Oct; 1113(1):86-93. PubMed ID: 16930565
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of delta9-THC on learning in adolescent and adult rats.
Cha YM; White AM; Kuhn CM; Wilson WA; Swartzwelder HS
Pharmacol Biochem Behav; 2006 Mar; 83(3):448-55. PubMed ID: 16631921
[TBL] [Abstract][Full Text] [Related]
11. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
Beraki S; Kuzmin A; Tai F; Ogren SO
Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
[TBL] [Abstract][Full Text] [Related]
12. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
13. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.
Holson RR; Ali SF; Scallet AC; Slikker W; Paule MG
Neurotoxicology; 1989; 10(3):605-19. PubMed ID: 2576305
[TBL] [Abstract][Full Text] [Related]
15. An ultra-low dose of tetrahydrocannabinol provides cardioprotection.
Waldman M; Hochhauser E; Fishbein M; Aravot D; Shainberg A; Sarne Y
Biochem Pharmacol; 2013 Jun; 85(11):1626-33. PubMed ID: 23537701
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
17. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
[TBL] [Abstract][Full Text] [Related]
18. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
19. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
Müller-Vahl KR; Koblenz A; Jöbges M; Kolbe H; Emrich HM; Schneider U
Pharmacopsychiatry; 2001 Jan; 34(1):19-24. PubMed ID: 11229617
[TBL] [Abstract][Full Text] [Related]
20. Motor effects of delta 9 THC in cerebellar Lurcher mutant mice.
Lorivel T; Hilber P
Behav Brain Res; 2007 Aug; 181(2):248-53. PubMed ID: 17531329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
